EMRİ, K. A. S. Et Al. 2017. Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma. Journal Of Thoracic Oncology , 723-724.

EMRİ, K. A. S., DİKMEN, Z. G., SARINÇ ULAŞLI, S., ESENDAĞLİ, d., YİLMAZ, u., ŞİMŞEK ÖZEK, N., ... SEVERCAN, F.(2017). Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma. Journal Of Thoracic Oncology , 723-724.

EMRİ, KAHRAMAN Et Al. "Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma," Journal Of Thoracic Oncology , 723-724, 2017

EMRİ, KAHRAMAN A. Et Al. "Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma." Journal Of Thoracic Oncology , pp.723-724, 2017

EMRİ, K. A. S. Et Al. (2017) . "Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma." Journal Of Thoracic Oncology , pp.723-724.

@article{article, author={KAHRAMAN AHMET SALİH EMRİ Et Al. }, title={Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma}, journal={Journal Of Thoracic Oncology}, year=2017, pages={723-724} }